Product Document Searching Made Easy by 2D Code! | [Product Highlights] Tetraphenylethylene Derivatives Used for...
Maximum quantity allowed is 999
CAS RN: 38243-03-7 | Product Number: G0536
20(R)-Ginsenoside Rg3
Purity: >97.0%(HPLC)
- (3β,12β,20R)-12,20-Dihydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
- 20(R)-Propanaxadiol
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 50MG |
₹12,800.00
|
Contact Us | 20 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | G0536 |
Purity / Analysis Method
|
>97.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__4__2H__7__2O__1__3 = 785.03 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 38243-03-7 |
| Reaxys Registry Number | 5720811 |
| MDL Number | MFCD11045225 |
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC)(CAD) | min. 97.0 area% |
| NMR | confirm to structure |
| RTECS# | LZ5780900 |
References
- 1) Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside ginsenoside-Rb2, 20(R)- and 20(R)-ginsenoside ginsenoside-Rg3, of Red ginseng
- 2) The angiosuppressive effects of 20(R)-ginsenoside ginsenoside Rg
- 3) Ginsenoside Rg3: potential molecular targets and therapeutic indication in metastatic breast cancer (a review)
- 4) Anti-angiogenic properties of ginsenoside Rg3 (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.
